Please Scroll Down to See Forums Below
INTERFERON - Beta 1a or 1b
- Thread starter tnheygirl
- Start date
Beta Interferons are produced by virus infected cells. They diffuse out to uninfected cells where they react with plasma or nuclear membranes to manufacture mRNA to synthesize antiviral protiens. these protiens are enzymes that dissrupt viral needs like protien synthesis and viral mRNA. They dont work in already infected cells though.....
Hope that is enough info for now???
I dont think this stuff will help you girl.
What the need for that stuff, if you dont mind me asking..?
Hope that is enough info for now???
I dont think this stuff will help you girl.
What the need for that stuff, if you dont mind me asking..?
Hey girl my ex had MS sorry to hear it, but kkeep on trucking there trouper well interferrons for MS are imune suppressing proteins of certain white blood cells which are ataking you myelin sheith (covering of the nerons your nerve cells), but any ways the bad news in the interferron will make you tired which sucks but ask your doctor about amantadine if you are already not on it.
ps how many attacks have you had
ps how many attacks have you had
A
alien amp pharm
Guest
bigrand said:
You aren't kidding! She is a hottie, but she is married
Her friends look hot too, hey I'm from Tennesse also! Humm.....
Being married doest change the beauty of the girl......
Anyway, here a little on interferons for MS and a few other treatment options......thanx to medscape.
Sidebar: Treating the Underlying Disease Process of MS[13-19]
Immunomodulating drugs control the immunologic cascade in MS that results in demyelination -- and ultimately in axonal damage, which occurs even during periods of remission. The first-generation immunomodulators (ie, proteins manufactured by the body in response to a foreign stimulus) are the beta interferons, interferon beta-1a and interferon beta-1b.[14-16]
Interferon beta-1b, available since the early 1990s for the treatment of relapsing-remitting MS, is usually self-administered as a subcutaneous injection every other day. Injection-site skin reactions are common, but they usually improve with time.
Interferon beta-1a is now available in two forms in the United States (one, injected intramuscularly once a week; the other, injected subcutaneously three times per week). Site injection reactions are uncommon. It is indicated to treat the relapsing forms of MS.
Treatment with the interferons may cause flu-like symptoms with elevated body temperature, particularly in patients who are young or small. These effects may be prevented or blunted by premedicating with antipyretics (eg, acetaminophen), nonsteroidal anti-inflammatory drugs (NSAIDs, eg, ibuprofen), low-dose corticosteroids (eg, prednisone), or pentoxifylline.[13,17] In young women, interferon use may be associated with mild menstrual irregularities.[13]
Glatiramer acetate, which is approved for treatment of relapsing MS, requires daily subcutaneous self-injection. Because it is a non-interferon, nonsteroidal agent, it does not produce the flu-like effects associated with interferon use; injection site reactions are common, however.
Naturally, the effectiveness of each of these therapies depends on the patient's adherence with the prescribed regimen. Self-administered daily injections require significantly more motivation than do four clinic visits a year.[18]
Mitoxantrone is a chemotherapeutic agent indicated only for treatment of worsening MS (not primary-progressive MS). Administered every three months as a five- to 15-minute intravenous infusion, this agent has been shown in clinical trials to significantly reduce neurologic disability and relapse rates.[19] Mitoxantrone use may lead to some degree of cardiac, hematologic, and/or hepatic toxicity, possibly limiting lifetime dosing. Common adverse effects include nausea, menstrual disorders (eg, amenorrhea), and urinary tract infection, but these are generally mild to moderate. Alopecia is an uncommon effect.
Anyway, here a little on interferons for MS and a few other treatment options......thanx to medscape.
Sidebar: Treating the Underlying Disease Process of MS[13-19]
Immunomodulating drugs control the immunologic cascade in MS that results in demyelination -- and ultimately in axonal damage, which occurs even during periods of remission. The first-generation immunomodulators (ie, proteins manufactured by the body in response to a foreign stimulus) are the beta interferons, interferon beta-1a and interferon beta-1b.[14-16]
Interferon beta-1b, available since the early 1990s for the treatment of relapsing-remitting MS, is usually self-administered as a subcutaneous injection every other day. Injection-site skin reactions are common, but they usually improve with time.
Interferon beta-1a is now available in two forms in the United States (one, injected intramuscularly once a week; the other, injected subcutaneously three times per week). Site injection reactions are uncommon. It is indicated to treat the relapsing forms of MS.
Treatment with the interferons may cause flu-like symptoms with elevated body temperature, particularly in patients who are young or small. These effects may be prevented or blunted by premedicating with antipyretics (eg, acetaminophen), nonsteroidal anti-inflammatory drugs (NSAIDs, eg, ibuprofen), low-dose corticosteroids (eg, prednisone), or pentoxifylline.[13,17] In young women, interferon use may be associated with mild menstrual irregularities.[13]
Glatiramer acetate, which is approved for treatment of relapsing MS, requires daily subcutaneous self-injection. Because it is a non-interferon, nonsteroidal agent, it does not produce the flu-like effects associated with interferon use; injection site reactions are common, however.
Naturally, the effectiveness of each of these therapies depends on the patient's adherence with the prescribed regimen. Self-administered daily injections require significantly more motivation than do four clinic visits a year.[18]
Mitoxantrone is a chemotherapeutic agent indicated only for treatment of worsening MS (not primary-progressive MS). Administered every three months as a five- to 15-minute intravenous infusion, this agent has been shown in clinical trials to significantly reduce neurologic disability and relapse rates.[19] Mitoxantrone use may lead to some degree of cardiac, hematologic, and/or hepatic toxicity, possibly limiting lifetime dosing. Common adverse effects include nausea, menstrual disorders (eg, amenorrhea), and urinary tract infection, but these are generally mild to moderate. Alopecia is an uncommon effect.
billyd0812
New member
ISNT INTERFERON
used in the tratment of hepatitus-C along with ribuvarin???
used in the tratment of hepatitus-C along with ribuvarin???
